Poland will suspend administration of the AstraZeneca vaccine, reserving remaining doses for people who have already received a first dose from the manufacturer.
The decision to stop administering the vaccine to those who have not received their first jab is linked to irregular deliveries and the producer’s failure to fulfil contracts, according to information obtained by Gazeta Wyborcza from the governmental Agency for Strategic Reserve.
In Poland, the interest in the AstraZeneca vaccine has decreased both due to problems with its supply and reports of rare cases of blood clotting.
Although the European Medicines Agency (EMA) has shown that such risks are minimal and that the benefits of the vaccine outweigh them many times over, the image of the vaccine, which was developed by researchers at Oxford University, has suffered badly.
About 1.7 million people in Poland are now waiting for their second AstraZeneca dose, while 974,000 have already had two doses. Last week, 868,000 doses of the AstraZeneca vaccine reached Poland, and a further 250,000 are due to arrive this week.
The Strategic Reserves Agency is currently making an inventory of unused doses of AstraZeneca in various regions of Poland and intends to hand them over to vaccination centres where they may be in short supply in the coming days for those waiting for their second dose.(Anna Wolska | EURACTIV.pl)